Non-invasive neuromodulation has become a budding intervention in preventing, managing and treating primary headaches including migraine. It has either substituted or at least reduced the dependence of migraineurs on anti-migraine drugs. Therefore, to study the influence and effectiveness of transcutaneous supraorbital (a kind of non-invasive neurostimulation) on various parameters of migraine headache attacks, relevant databases were obtained from PubMed, MEDLINE, Research Gate, Scopus and Google Scholar. The studies which included migraine and transcutaneous supraorbital stimulation were selected for the analysis. The included studies account for the randomized controlled trials, open label preliminary studies, and comparative studies published in English language over the span of 2013 to 2023. 12 records were included for the synthesis. Transcutaneous supraorbital stimulation (tSNS), as an intervention for treating migraine has shown favorable results especially in cases of refractory migraine. It has successfully aided in preventing the drug resistance which frequently develops on consumption of associated drugs over a long period of time. Hence, tSNS can be considered an appropriate alternative for the conventional pharmacological treatment regimen followed in migraineurs.